I.

Rationale
The Expanded Program on Immunization (EPI) was established in 1976 to ensure that infants/children
and mothers have access to routinely recommended infant/childhood vaccines. Six vaccine-preventable
diseases were initially included in the EPI: tuberculosis, poliomyelitis, diphtheria, tetanus, pertussis and
measles. In 1986, 21.3% “fully immunized” children less than fourteen months of age based on the EPI
Comprehensive Program review.
II. Scenario
Global Situation
The burden
In 2002, WHO estimated that 1.4 million of deaths among children under 5 years due to diseases that
could have been prevented by routine vaccination. This represents 14% of global total mortality in
children under 5 years of age.

Source: Weekly Epidemiological Record, WHO: No.46,2011,86.509-520)

Burden of Diseases
The immunization coverage of all individual vaccines has improved as shown in Figure 1: (Demographic
Health Survey 2003 and 2008). Fully Immunized Child (FIC) coverage improved by 10% and the Child
Protected at Birth (CPAB) against Tetanus improved by 13% compared to any prior period. Thus, the
Philippines has now historically the highest coverage for these two major indicators.
Figure 1: Comparison of the 2003 and 2008 EPI indicators, Source: NDHS

Comparison of the 2003 and 2008 EPI indicators, Source: NDHS

III. Interventions/ Strategies

Program Objectives/Goals:
Over-all Goal:
To reduce the morbidity and mortality among children against the most common vaccine-preventable
diseases.
Specific Goals:
1. To immunize all infants/children against the most common vaccine-preventable diseases.

2. To sustain the polio-free status of the Philippines.

3. To eliminate measles infection.

4. To eliminate maternal and neonatal tetanus

5. To control diphtheria, pertussis, hepatitis b and German measles.

6. To prevent extra pulmonary tuberculosis among children.

Mandates:
Republic Act No. 10152“MandatoryInfants and Children Health Immunization Act of 2011Signed by
President Benigno Aquino III in July 26, 2010. The mandatory includes basic immunization for children
under 5 including other types that will be determined by the Secretary of Health.

Strategies:
• Conduct of Routine Immunization for Infants/Children/Women through the Reaching Every
Barangay (REB) strategy
REB strategy, an adaptation of the WHO-UNICEF Reaching Every District (RED), was introduced
in 2004 aimed to improve the access to routine immunization and reduce drop-outs. There are 5
components of the strategy, namely: data analysis for action, re-establish outreach services, , strengthen
links between the community and service, supportive supervision and maximizing resources.

• Supplemental Immunization Activity (SIA)

Supplementary immunization activities are used to reach children who have not been vaccinated
or have not developed sufficient immunity after previous vaccinations. It can be conducted either
national or sub-national –in selected areas.

• Strengthening Vaccine-Preventable Diseases Surveillance

This is critical for the eradication/elimination efforts, especially in identifying true cases of measles and
indigenous wild polio virus

• Procurement of adequate and potent vaccines and needles and syringes to all health facilities
nationwide
IV. Status of implementation/ Accomplishment
• All health facilities (health centers and barangay health stations) have at least one (1) health
staff trained on REB.

Polio Eradication:
• The Philippines has sustained its polio-free status since October 2000.
• Declining Oral Polio Vaccine (OPV) third dose coverage since 2008 from 91% to 83%. A least 95%
OPV3 coverage need to be achieved to produce the required herd immunity for protection.

Figure 2 OPV1 and OPV3 Coverage, Philippines, 2005-2010

OPV1 and OPV3 Coverage, Philippines, 2005-2010

• There is an on-going polio mass immunization to all children ages 6 weeks up to 59 months old
in the 10 highest risk areas for neonatal tetanus. These areas are the following: Abra, Banguet,
Isabela City and Basilan, Lanao Norte, Cotabato City, Maguindanao, Lanao Sur, Marawi City and
Sulu.
• Acute Flaccid Paralysis (AFP) reporting rate has decreased from 1.44 in 2010 to 1.38 in 2011.
Only regions III, V and VIII have achieved the AFP rate of 2/100,000 children below 15 years old.
(Source: NEC, DOH). A decreasing AFP rate means we may not be able to find true cases of polio
and may experience resurgence of polio cases

Measles Elimination
• Conducted 4 rounds of mass measles campaign: 1998, 2004, 2007 and 2011.
• Implemented the 2-dose measles-containing vaccine (MCV) in 2009
MCV1 (monovalent measles) at 9-11 months old
MCV2 (MMR) at 12-15 months old.
• Implemented and strengthened the laboratory surveillance for confirmation of measles. Blood
samples are withdrawn from all measles suspect to confirm the case as measles infection.
• A supplemental immunization campaign for measles and rubella (German measles) was done in
2011. This was dubbed as “Iligtas sa Tigdas ang Pinas” 15.6 million (84%) out of the 18.5 million
children ages 9 months to 8 years old were given 1 dose of the measles-rubella (MR) vaccine
between April and June 2011.
• Rapid coverage assessment (RCA) were conducted in selected areas to validate immunization
coverage, assess high quality and that there are NO missed child in every barangay. Overall RCA
 results showed that 70,594 (97.6%) out of 72,353 9 months to 8 years old living in the randomly
selected barangays were vaccinated. There are 3,494 barangays with a population of 1000 and
above that were randomly selected. 97.6% of all eligible children were given the MR vaccine
during the immunization campaign.
• The Government of the Philippines spent PhP 635.7M for the successful conduct of the MR
campaign.ss high quality and that there are NO missed child in every barangay. Overall RCA
results showed that 70,594 (97.6%) out of 72,353 9 months to 8 years old living in the randomly
selected barangays were vaccinated. There are 3,494 barangays with a population of 1000 and
above that were randomly selected. 97.6% of all eligible children were given the MR vaccine
during the immunization campaign.
• As of Morbidity Week 8 of 2012, there were 92 confirmed cases: 60 cases were laboratory
confirmed, 5 cases were epidemiologically-linked and 27 clinically confirmed. This means we
have at least 60 “true” measles at present. Measles is said to be eliminated if we have 1 case per
million or below 100 cases in a year

Maternal and Neonatal Tetanus Elimination

• 10 areas were classified as highest risk for neonatal tetanus (NT). Figure 3 shows the areas
categorized as low risk, at risk and highest risk based on the NT surveillance, skilled birth
attendants and facility based delivery and the tetanus toxoid 2+ (TT 2+) vaccination.
Figure 3: Level of Risk for NT, Philippines

• Three (3) rounds of TT vaccination are currently on-going in the 10 highest risk areas. An
estimated 1,010,751 women age 15 - 40 year old women regardless of their TT immunization will
receive the vaccine during these rounds. This is funded by the Kiwanis International through
UNICEF and World Health Organization.

Control of other common vaccine-preventable diseases (Diphtheria, Pertussis, Hepatitis B and

Meningitis/Encephalitis secondary to H. influenzae type B)
Continuous vaccination for infants and children with the DPT or the combination DPT-HepB-HiB Type B.
Annex1 EPI Annual Accomplishment Report. DOH procures all the vaccines and needles and syringes for
the immunization activities targeted to infants/children/mothers.

Hepatitis B Control
 • Republic Act No. 10152 has been signed. It is otherwise known as the “Mandatory Infants and
Children Health Immunization Act of 2011, which requires that all children under five years old
be given basic immunization against vaccine-preventable diseases. Specifically, this bill provides
for all infants to be given the birth dose of the Hepatitis-B vaccine within 24 hours of birth.
• One strategy to strengthen Hepatitis B coverage is to integrate birth dose in the Essential
Intrapartum and Newborn Care Package (EINC). In 2011, 11 tertiary hospitals are already EINC
compliant.
• The goal of Hepatitis B control is to reduce the chronic hepatitis B infection rate as measured by
HBsAg prevalence to less than 1% in five-year-olds born after routine vaccination started 100%
Hepatitis B at birth vaccination.
Figure 4 Hepatitis B Coverage. Philippines, 2001-2011
Timing of administration/dose 2009 2010* 2011*
<24 hours 34% 38% 14%
>24 hours 62% 55% 24%
Hep B 3rd dose 86% 81% 30%
*both 2010 and 2011 data are as of October 2011

Vaccines and cold chain management

• Upgraded the cold chain equipment in the 80 provinces, 38 cities and 16 regions since 2003.
• An effective vaccine management assessment was conducted last December 2011 and revealed
cold chain capacity gaps from the national up to the implementers level.
• A total of Php267 million is required to address the gaps identified during the assessment.

Introduction to New Vaccines

• For 2012, Rotavirus and Pneumococcal vaccines will be introduced in the national immunization
program. Immunization will be prioritized among the infants of families listed in the National
Housing and Targeting System (NHTS) for Poverty Reduction nationwide.
• The Government of the Philippines has allocated PhP 1.6 billion for the procurement of these 2
vaccines.

V. Future Plan/ Action

• Strengthening the Cold Chain to support the Immunization Program

• Capacity Building for Health Workers for the Introduction of New Vaccines
• Advocacy for the financial sustainability for the newly introduced vaccines for expansion.
 • Development of the comprehensive multi-year plan for immunization program.

VI. Other Significant information worth mentioning

• One significant milestone is that the budget allocation for the immunization program has
continued to increase year by year
• The Government of the Philippines allocated budget for the immunization of all
infants/children/women/older persons nationwide. For 2012, the budget for EPI is PhP1.8 billion
and another P1.5 Billion for the immunization for senior citizen and children for the NHTS
families. This is great leap towards universal access to quality vaccines for the prevention of the
most common vaccine-preventable diseases.